Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test, the company announced today. It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk.
23andMe Initiates Phase 1 Clinical Trial for First Wholly-Owned Immuno-oncology Antibody for Patients with Solid Tumors
23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced the first participant has been dosed in a Phase 1 clinical trial evaluating 23ME-00610 for the treatment of advanced solid tumors.
DailyPay, featured in TIME’s “Best Inventions of 2021,” today announced their one-of-a-kind digital wallet solution. DailyPay’s digital wallet solution is designed for everyday working Americans, many of whom are facing unprecedented financial challenges with the resurgence of the pandemic.
HealthCare.com, a leading data-driven insurtech platform, announced today the closing of $130 million in Senior Non-Convertible Preferred and more than $50 million of Series C Preferred equity in an oversubscribed round led by funds managed by Oaktree Capital Management, L.P. (“Oaktree”).
UserTesting, Inc. (“UserTesting”), a leading provider of human insight, delivered through a video-first, experience testing platform, today announced the pricing of its initial public offering of 10,000,000 shares of common stock at a public offering price of $14.00 per share.
Prove, the modern way for businesses to enable their customers to prove their identities with just a phone, announced today that its Prove Pre-Fill™ and other onboarding solutions now include Know Your Customer (KYC) and anti-money laundering (AML) checks, including sanctions, watchlists, and politically exposed persons (PEP) screening at no additional cost.
Bespoke Post, a multi-category e-commerce retailer, announces a $40 million Series B funding round led by NewSpring to fuel the rapid growth of the business and hone in on their efforts to help customers discover the most unique small brands.
23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced the signing of a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online.
UserTesting, Inc. (“UserTesting”), a leading provider of human insight, delivered through a video-first, enterprise SaaS platform, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock.
In July, the White House issued an executive order asking the CFPB to work on rules for secure data sharing between consumers and banks. The order intends to promote healthy competition in financial services, enabling consumers with better choices and improving security in financial data exchange.
Travel startups continue to rake in venture capital dollars as more people become comfortable traveling amid the global pandemic. The latest is SmarterTravel, which brought in $9.5 million in Series B funding co-led by Link Ventures and Second Alpha, with existing investors also participating.
23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced the completion of their previously announced business combination.
DailyPay, the leader in on-demand pay solutions for enterprises, today announced it has secured $500 million of capital. The company is announcing a $175 million Series D equity round led by Carrick Capital Partners with participation from existing investors.
Coursera, Inc. (“Coursera”) today announced the pricing of its initial public offering of an aggregate of 15,730,000 shares of its common stock at a price to the public of $33.00 per share. The offering includes 14,664,776 shares of common stock to be issued and sold by Coursera and 1,065,224 shares of common stock to be sold by the selling stockholders.
ON24, Inc. (NYSE:ONTF) today announced the pricing of its initial public offering of 8,560,930 shares of common stock at a price to the public of $50.00 per share. ON24 is offering 6,315,789 shares of common stock and certain selling stockholders are offering 2,245,141 shares of common stock.